BIO Top Job May Go To Rep. Greenwood
This article was originally published in The Pink Sheet Daily
Oversight Subcommittee chairman confirms he is considering leaving Congress to pursue a new opportunity, but says he will have no further comment until he makes a decision "in the very near future." Greenwood has been among most active legislators on pharmaceutical issues, and has worked with BIO on stem cell and human subject protection proposals.
You may also be interested in...
A scientist may provide a certain look, but understanding politics is more important to ensuring the health of the pharma industry, the outgoing president and CEO of BIO said in an interview.
Long-time CEO of the Biotechnology Innovation Organization will remain until after the 2020 election and help with the leadership transition.
The Pennsylvania Republican will serve out his term before becoming president of the trade association. Greenwood emphasizes the promise of stem cell research as a reason for taking the Biotechnology Industry Organization post.